Cisplatin, Gemcitabine, and Paclitaxel as a Salvage Second-Line Therapy for Metastatic Germ-Cell Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cisplatin, Gemcitabine, and Paclitaxel as a Salvage Second-Line Therapy for Metastatic Germ-Cell Cancer

Published:2021-02 Issue:1 Volume:19 Page:e6-e11
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Fujiwara Motohiro,Hayashi Tatsuro,Takeda Hayato,Yuasa Takeshi,Komai Yoshinobu,Numao Noboru,Yamamoto Shinya,Fukui Iwao,Kouno Tsutomu,Yonese Junji

Funder

Smoking Research Foundation

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference22 articles.

1. Current status of chemotherapy in risk-adapted management for metastatic testicular germ cell cancer;Kawai;Cancer Sci,2010

2. Clinical characteristics and oncological outcomes of testicular cancer patients registered in 2005 and 2008: the first large-scale study from the Cancer Registration Committee of the Japanese Urological Association;Miki;Int J Urol,2014

3. Guidelines on testicular cancer: 2015 update;Albers;Eur Urol,2015

4. International Germ Cell Consensus Classification: a prognostic factor–based staging system for metastatic germ cell cancers;J Clin Oncol,1997

5. Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B study;Nichols;J Clin Oncol,1998

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary mediastinal choriocarcinoma in a woman treated with VIP therapy instead of BEP therapy for the prevention of postoperative acute respiratory distress syndrome;International Cancer Conference Journal;2024-08-05

2. Simple predictors for the completion of scheduled gemcitabine‑cisplatin regimens based on real‑world urothelial cancer data;Molecular and Clinical Oncology;2024-04-01

3. Editorial Comment to Plasma circulating tumor DNA profiling in patients with chemo‐refractory germ cell tumors;International Journal of Urology;2023-02-23

4. First‐line combination chemotherapy with etoposide, ifosfamide and cisplatin for the treatment of disseminated germ cell cancer: Efficacy and feasibility in current clinical practice;International Journal of Urology;2021-05-24

5. Cisplatin/gemcitabine/paclitaxel;Reactions Weekly;2021-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3